Ignite Creation Date:
2024-05-05 @ 4:49 PM
Last Modification Date:
2024-10-26 @ 9:25 AM
Study NCT ID:
NCT00328172
Status:
COMPLETED
Last Update Posted:
2014-03-14
First Post:
2006-05-18
Brief Title:
Efficacy and Safety of 3 Doses of BI1356 Linagliptin in Type 2 Diabetes Patients
Sponsor:
Boehringer Ingelheim
Organization:
Boehringer Ingelheim
Conditions & Keywords Data
Conditions:
| Name |
|---|
| Diabetes Mellitus Type 2 |
Keywords: